APA (7th ed.) Citation

A, S., S, R., C, M., F, B., & C, K. (2024). Necessity of Tobramycin trough Levels in Once Daily Iv-Treatment in Patients with Cystic Fibrosis. Klinische Padiatrie, 236(2), 116. https://doi.org/10.1055/a-2244-6903

Chicago Style (17th ed.) Citation

A, Schlegtendal, Rettberg S, Maier C, Brinkmann F, and Koerner-Rettberg C. "Necessity of Tobramycin Trough Levels in Once Daily Iv-Treatment in Patients with Cystic Fibrosis." Klinische Padiatrie 236, no. 2 (2024): 116. https://doi.org/10.1055/a-2244-6903.

MLA (9th ed.) Citation

A, Schlegtendal, et al. "Necessity of Tobramycin Trough Levels in Once Daily Iv-Treatment in Patients with Cystic Fibrosis." Klinische Padiatrie, vol. 236, no. 2, 2024, p. 116, https://doi.org/10.1055/a-2244-6903.